GSS genetic signatures limited

GSS upside potential, page-8

  1. 69 Posts.
    lightbulb Created with Sketch. 5
    For companies like GSS, it seems that a rule of thumb applies where the global revenue tends to be 20x Australian revenue. With the current product maturity level, this implies a prospective global revenue of ~100m if FDA approval is forthcoming. That would put a real rocket under the market.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
39.5¢
Change
0.005(1.28%)
Mkt cap ! $89.71M
Open High Low Value Volume
39.5¢ 39.5¢ 39.5¢ $304 769

Buyers (Bids)

No. Vol. Price($)
1 5000 37.5¢
 

Sellers (Offers)

Price($) Vol. No.
40.0¢ 95869 1
View Market Depth
Last trade - 11.30am 18/07/2025 (20 minute delay) ?
GSS (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.